Skip to content
Open access

P324 - ECE_2476 - The impact of waist to height ratio in the assessment of women with polycystic ovary syndrome. Evidence from a large European cohort

Aug 2026 · European Journal of Endocrinology · Vol 195 · 0 citations

TL;DR

It is suggested that WHtR captures a distinct aspect of PCOS pathophysiology as it integrates both metabolic and androgenic interaction in PCOS and emerges as a pragmatic anthropometric marker for early metabolic risk stratification in PCOS.

Abstract

Women suffering from PCOS display a variety of metabolic and hormonal abnormalities. Waist to height ratio (WHtR,), is considered as a valuable predictor of cardiovascular risk and central obesity. To assess the association of WHtR with metabolic/hormonal profile in PCOS. Data from 2201 PCOS women, mean age 25.0 years (21-29), BMI 24.7 kg/m2 (21.3-30.80) were analyzed. Participants were classified into three WHtR categories according to the established cut-offs (A: <0.50, B: 0.50-0.59, C: ≥0.60). Findings are presented before and after adjustment for age and BMI. A gradual statistically significant increase was observed among subgroups regarding HOMA-IR [A: 1.5 (0.9-2.3), B: 2.7 (1.6-4.0), C: 4.2 (2.6-6.3)] and the existence of impaired glucose tolerance (IGT) [A: 7.3%, B: 12.4%, C: 24.0%], (P for trend <.001). The relationship of HOMA-IR with WHtR remained statistically significant (P < .001) even after adjustment for age and BMI. These subgroups were also associated with a progressively adverse lipid profile, characterized by higher triglyceride [A: 78 (58-102), B: 89 (67-111), C: 96 (75-142)mg/dl] and LDL cholesterol levels [A: 108 (86-133), B: 114 (94-139), C: 118.0 (98-133)mg/dl] and lower HDL cholesterol concentrations [A: 51(43-61), B: 51 (42-57), C: 45 (40-54)mg/dl], with strong linear trends across WHtR strata. Notably, the associations with triglycerides and HDL cholesterol persisted after adjustment for age and BMI (P < .001). Considering, hormonal profile, subgroups based on WHtR categories were associated with a progressive increase in free androgen index (FAI) [A: 4.97 (3.07-7.66), B: 7.49 (4.54-11.11), C: 9.38 (6.00-13.90)] and the prevalence of hirsutism [A: 55.5%, B: 61.8%, C: 69.3%] (P for trend <.001). Total testosterone levels showed a modest, but significant increase across WHtR strata, whereas DHEAS, D4 and 17OP concentrations did not differ significantly. Gonadotropins exhibited an inverse association with WHtR, with lower LH and FSH levels observed in higher WHtR categories, while TSH showed only a weak trend. In multivariate analyses, sugbroups were strongly associated with increased FAI values in a graded manner, and these associations remained statistically significant after adjustment for age and BMI (P < .001). Multivariate analysis showed that WHtR constitutes a solid denominator of insulin resistance, dyslipidemia and hyperandrogenemia even after adjustment of age and BMI. These findings suggest that WHtR captures a distinct aspect of PCOS pathophysiology as it integrates both metabolic and androgenic interaction in PCOS and emerges as a pragmatic anthropometric marker for early metabolic risk stratification in PCOS.

Read PDF

Similar papers

Review Open access Aug 2026

Leptin, adiponectin levels and their ratios in women with polyendocrine metabolic ovarian syndrome: a systematic review and meta-analysis

Women with PMOS aged 18–49 exhibit higher leptin levels, lower adiponectin levels and a lower A/L ratio, as well as the adiponectin-to-leptin (A/L) ratio, compared with healthy controls aged 18–49.

Xiao-Meng Shi, Wen-Ting Zhang · 0 citations
Open access Sep 2026

Association of prolactin with cardiometabolic risk markers in women with polycystic ovary syndrome: a phenotype-based analysis

Compared with controls, women with PCOS had higher body weight, body-mass index, waist circumference, waist circumference, triglyceride levels, insulin resistance-related parameters, triglyceride-glucose (TyG) Index, lipid accumulation product (LAP), and Atherogenic Index of Plasma (AIP), whereas high-density lipoprote...

Hatice Çalışkan Burgucu, Emel Yılmaz Kaya, Ayşen Yümlü et al. · 0 citations
Open access Sep 2026

Ovarian Morphology and Doppler Vascular Patterns in Women with and Without Polycystic Ovarian syndrome: Associations with Body Mass Index

It is demonstrated that women with PCOS had higher BMI values and were more likely to present with clinical features such as irregular menstrual cycles, acne, and hirsutism compared with non-PCOS women.

Shokhan Ahmed Hussein, Noor Sami Omar, Lezan Jalal Ali Shah et al. · 0 citations
Open access Aug 2026

Common inflammatory markers in polycystic ovary syndrome (PCOS): a BMI-matched case–control study.

Background: Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder associated with low-grade inflammation.  Aim: To compare inflammatory markers between women with PCOS and age- and BMI-matched controls and assess their metabolic associations.  Materials and Methods: This hospital-based case–control...

S. Jinger, Priyanka Songara, Kshatrapal Dabi · 0 citations
Review Open access Aug 2026

Beyond PCOS: hormonal determinants of insulin resistance in normal-weight women of reproductive age - a scoping review

Background/Purpose: Insulin resistance (IR) in normal-weight women is poorly understood and traditionally associated almost exclusively with polycystic ovary syndrome (PCOS). We aimed to map the available literature on the hormonal determinants of IR in normal-weight women of reproductive age. Methods: The review is c...

Aleksandra Misarko, Iga Woźniakowska, Maja Zambrzycka et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.